ADCY10 and cervical squamous intraepithelial neoplasia: PRP4K acts as a key regulator of the SAC during mitosis, and thus its loss alters therapy responses to microtubule targeting chemotherapy and although not experimentally validated, likely also drives CIN during cancer development.